WPRIM Management System> DCMS> Acta Pharmaceutica Sinica> 2020> 55> 2

Volume: 55 Issue: 2

1. Potential mechanism of Huangqin decoction for the treatment of ulcerative colitis based on network pharmacology Page:247—255
2. Triterpenoids from Galbanumofuygur medicine andtheir anticholinesterase activities Page:283—288
3. Network pharmacology study on anti-stroke of Xiaoshuan Tongluo formula based on systematic compound-target interaction prediction models Page:256—264
4. Determination of mexiletine hydrochloride by rose Bengal probe using dual-wavelength resonance light scattering technology Page:298—304
5. Antidepressant-like effects of the petroleum ether fraction of Xiaoyaosan in the CUMS rat model of depression Page:305—314
6. Meridian tropism of Scutellaria baicalensis based on molecular thermodynamic characteristics Page:330—334
7. Progress in pharmacokinetics of oral transmucosal drug delivery systems Page:226—234
8. Effects of Guilingji on serum metabolites in D-galactose-induced aging in rats Page:315—322
9. The key role of mitochondrial energy metabolism disorder in the pathogenesis of depression Page:195—200
10. Research progress on the role and mechanism of Wnt signaling pathway in neuropathic pain Page:201—207
11. Effect of wuzhi capsules on the blood concentration of tacrolimus relative to diltiazem and CYP3A5 gene polymorphisms Page:272—275
12. Mechanisms of rapamycin on regulating rat mesangial cell proliferation and cell cycle through mTORC1/p70S6K pathways Page:235—240
13. Attenuating the potential hepatotoxicity of Psoraleae Fructus by pre-processing: the alcohol soaking and water rinsing method Page:276—282
14. Current advances in research on adjuvant therapy for cerebral malaria Page:208—217
15. The mechanism of anti-hepatocellular carcinoma cell line HepG2 by Chinese medicine Astragalus protein Page:241—246
16. Establishment of an in vitro screening model for uranium decorporation chelators based on the competitive ELISA method Page:265—271
17. Cloning and analysis of the DXR gene and its promoter in Morinda officinalis Page:335—344
18. A new alkaloid from Rehmanniae Radix Preparata Page:289—293
19. Advances in molecular mechanisms for enhanced hepatic lipogenesis in insulin resistance Page:189—194
20. Construction of a concentration gradient microfluidic chip platform for the rapid screening of drugs active against Candida albicans Page:323—329
21. A new alkaloid from Alstonia yunnanensis Page:294—297
22. Progress in clinical pharmacology of oligonucleotides Page:218—225
23. Strategies for the development of drugs targeting novel coronavirus 2019-nCoV Page:181—188